Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online January 11, 2008
Diabetes 57:1063-1068, 2008
DOI: 10.2337/db07-1292
© 2008 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online-Only Appendix
Right arrow All Versions of this Article:
db07-1292v1
57/4/1063    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Cheurfa, N.
Right arrow Articles by Velho, G.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cheurfa, N.
Right arrow Articles by Velho, G.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The Common –866G>A Variant in the Promoter of UCP2 Is Associated With Decreased Risk of Coronary Artery Disease in Type 2 Diabetic Men

Nadir Cheurfa1, Danièle Dubois-Laforgue2, Daniela A.F. Ferrarezi1,3, André F. Reis4, Guilherme M. Brenner1,5, Clara Bouché2, Claude Le Feuvre6, Frédéric Fumeron1,7, José Timsit2,8, Michel Marre1,7, and Gilberto Velho1

1 Institut National de la Santé et de la Recherche Médicale, Research Unit 695, Paris, France
2 Department of Immunology and Diabetology, AP-HP Cochin Hospital, Paris, France
3 Laboratory of Cellular and Molecular Endocrinology, São Paulo University, São Paulo, Brazil
4 Laboratory of Molecular Endocrinology, Federal University of São Paulo, São Paulo, Brazil
5 Post-Graduation Program in Medical Sciences, Federal Faculty Foundation of Medical Sciences of Porto Alegre, Porto Alegre, Brazil
6 Department of Cardiology, Assistance Publique–Hôpitaux de Paris, La Pitié Hospital, Paris, France
7 Université Denis Diderot Paris 7, Paris, France
8 Université René Descartes Paris 5, Paris, France

Address correspondence and reprint requests to Dr. Gilberto Velho, Institut National de la Santé et de la Recherche Médicale U-695, Faculté de Médecine Xavier Bichat, 16 rue Henri Huchard, 75018 Paris, France. E-mail: velho{at}bichat.inserm.fr

Abbreviations: CABG, coronary artery bypass graft; CAD, coronary artery disease; DIABHYCAR Study, Non-Insulin-Dependent Diabetes, Hypertension, Microalbuminuria, Cardiovascular Events, and Ramipril Study; NCH, Necker and Cochin Hospitals; ROS, reactive oxygen species; SNP, single nucleotide polymorphism; UAC, urinary albumin concentration; UCP2, uncoupling protein 2

OBJECTIVE—Uncoupling protein 2 (UCP2) is a physiological downregulator of reactive oxygen species generation and plays an antiatherogenic role in the vascular wall. A common variant in the UCP2 promoter (–866G>A) modulates mRNA expression, with increased expression associated with the A allele. We investigated association of this variant with coronary artery disease (CAD) in two cohorts of type 2 diabetic subjects.

RESEARCH DESIGN AND METHODS—We studied 3,122 subjects from the 6-year prospective Non–Insulin-Dependent Diabetes, Hypertension, Microalbuminuria, Cardiovascular Events, and Ramipril (DIABHYCAR) Study (14.9% of CAD incidence at follow-up). An independent, hospital-based cohort of 335 men, 52% of whom had CAD, was also studied.

RESULTS—We observed an inverse association of the A allele with incident cases of CAD in a dominant model (hazard risk 0.88 [95% CI 0.80–0.96]; P = 0.006). Similar results were observed for baseline cases of CAD. Stratification by sex confirmed an allelic association with CAD in men, whereas no association was observed in women. All CAD phenotypes considered—myocardial infarction, angina pectoris, coronary artery bypass graft (CABG), and sudden death—contributed significantly to the association. Results were replicated in a cross-sectional study of an independent cohort (odds ratio 0.47 [95% CI 0.25–0.89]; P = 0.02 for a recessive model).

CONCLUSIONS—The A allele of the –866G>A variant of UCP2 was associated with reduced risk of CAD in men with type 2 diabetes in a 6-year prospective study. Decreased risk of myocardial infarction, angina pectoris, CABG, and sudden death contributed individually and significantly to the reduction of CAD risk. This association was independent of other common CAD risk factors.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2008 by the American Diabetes Association.